[Complications of the 180 Watt XPS™ GreenLight Laser-results of 1283 procedures]

Overview

Journal Urologie

Specialty Urology

Date 2022 Dec 13

PMID 36513771

Authors

F Fallahi

M Fallahi

R Brauckmann

S Brandt

J Horstmann

A Wiedemann

Affiliations

Soon will be listed here.

Abstract

Background: The aim of this study was to classify and analyze postoperative complications under a new inspection method. This study assessed all patients who presented to the urologic ward within the first 3 months after their surgery.

Methods: A total of 170 patients suffered from complications due to the surgery; 29 patients experienced complications that were not directly correlated with the surgery. Age, American Society of Anesthesiologists (ASA) score, the emitted laser energy of the 180 Watt XPS™ GreenLight laser measured in joules, and the complications which led to the renewed hospitalization such as hematuria, urinary retention, and infection were analyzed and compared in the two groups of patients.

Results: Most complications that occurred were urinary retention and hematuria (50.6% and 49.4% of all patients, respectively). Of the patients with hematuria, 86.75% were under anticoagulant therapy medication.

Conclusion: Compared with the reference approval study (Goliath trial) that included 135 multicentric patients (14.07% of patients presented with a complication classified as Clavien-Dindo II), the rate of complications was similar. This outcome is surprising because the patients treated with the GreenLight laser in the present study were classified as geriatric patients not only according to their age but also in their ASA score which is an indication of multiple other pathologies and administered medications. To achieve long-term postoperative success for these patients, the interface between the ambulatory and the hospital care should be optimized.

References

Bachmann A, Tubaro A, Barber N, dAncona F, Muir G, Witzsch U . 180-W XPS GreenLight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of a European Multicentre Randomised Trial--the GOLIATH study. Eur Urol. 2013; 65(5):931-42. DOI: 10.1016/j.eururo.2013.10.040. View

Berges R, Dreikorn K, Hofner K, Madersbacher S, Michel M, Muschter R . [Therapy of benign prostate syndrome (BPS): guidelines of the German Urologists (DGU)]. Urologe A. 2009; 48(12):1503-16. DOI: 10.1007/s00120-009-2067-4. View

Bachmann A, Tubaro A, Barber N, dAncona F, Muir G, Witzsch U . A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study. J Urol. 2014; 193(2):570-8. DOI: 10.1016/j.juro.2014.09.001. View

Lichtenberg T, Wiedemann A, Heppner H . [Comparison of 180 W Greenlight-XPS laser vaporisation and transurethral resection of the prostate: comfort for patients and healthcare staff in clinical routine practice]. Aktuelle Urol. 2020; 51(1):59-64. DOI: 10.1055/a-1069-7103. View

Ferrari L, Leahy I, Staffa S, Johnson C, Crofton C, Methot C . One Size Does Not Fit All: A Perspective on the American Society of Anesthesiologists Physical Status Classification for Pediatric Patients. Anesth Analg. 2019; 130(6):1685-1692. DOI: 10.1213/ANE.0000000000004277. View